Chemoinformaics analysis of 2,5,9-Trimethyldecane
Molecular Weight | 184.367 | nRot | 7 |
Heavy Atom Molecular Weight | 156.143 | nRig | 0 |
Exact Molecular Weight | 184.219 | nRing | 0 |
Solubility: LogS | -6.411 | nHRing | 0 |
Solubility: LogP | 6.276 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 41 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 40.3802 |
nHD | 0 | BPOL | 28.0898 |
QED | 0.528 |
Synth | 2.48 |
Natural Product Likeliness | 1.012 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.005 |
HIA | 0.004 |
CACO-2 | -4.32 |
MDCK | 0.0000149 |
BBB | 0.499 |
PPB | 0.976936 |
VDSS | 2.491 |
FU | 0.0254644 |
CYP1A2-inh | 0.42 |
CYP1A2-sub | 0.284 |
CYP2c19-inh | 0.453 |
CYP2c19-sub | 0.873 |
CYP2c9-inh | 0.624 |
CYP2c9-sub | 0.958 |
CYP2d6-inh | 0.017 |
CYP2d6-sub | 0.048 |
CYP3a4-inh | 0.071 |
CYP3a4-sub | 0.166 |
CL | 7.649 |
T12 | 0.113 |
hERG | 0.021 |
Ames | 0.004 |
ROA | 0.034 |
SkinSen | 0.698 |
Carcinogencity | 0.056 |
EI | 0.98 |
Respiratory | 0.153 |
NR-Aromatase | 0.003 |
Antiviral | Yes |
Prediction | 0.571356 |